Sun Pharmaceutical Industries Ltd - 524715 - Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing on https://economictimes.indiatimes.com May 13, 2019 titled "Pharma stocks bleed as US states file lawsuit against generic drug firms ". The reply is awaited. Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Advertisement regarding Notice of the National Company Law Tribunal ('NCLT') Convened Meetings of the Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Notice Of Board Meeting For Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Fourth Quarter And Year Ended March 31, 2019 And To Consider Recommendation Of Dividend For The Year Ended March 31, 2019
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, May 28, 2019, inter alia, to transact following business: (i) To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2019. (ii) To consider recommendation of dividend for the year ended March 31 , 2019 subject to the approval of the shareholders at the ensuing Annual General Meeting. Further, kindly note that pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on April 4, 2019, and shall end after 48 hours of the declaration of financial results of the Company on May 28, 2019. This is for your information and record. Today's picks: From Sun Pharma to Britannia, hot stocks to buy on Thursday
Target prices, projected movements in terms of next session, unless otherwise stated Today's picks: From Sun Pharma to Tata Motors, hot stocks to buy on Tuesday
For Sun Pharma, keep a stop at Rs 457 and go short SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd We have big expectations from Japan and China: Sun Pharma's Dilip Shanghvi
Shangvi feels the domestic market is big enough to accommodate both branded and unbranded medicines US FDA seeks voluntary action on Dadra plant for Sun
Sun Pharma's shares had fallen last week over this development as investors worried about delay in product launches from the company. Sun Pharma falls after USFDA observations on company's Dadra plant
Sun Pharma's shares fell nearly 2 per cent on Tuesday.The USFDA on Friday issued Form 483 with 11 observations after inspection of the company's Dadr